Pharmaceutical industry clean plant and laboratory intelligent construction project observation seminar held in Lanzhou
DATE:2025-05-16
Read:
SHARE:
In order to deeply implement the spirit of the 20th CPC National Congress and the 3rd Plenary Session of the 20th CPC Central Committee, fully implement the relevant requirements of the “Guidelines for Intelligent Construction Technology (Trial)” and the “Implementation Plan for the Digital and Intelligent Transformation of the Pharmaceutical Industry (2025-2030)”, to promote the popularization and application of digital intelligence and intelligent construction technology, and to empower the high-quality development of high-tech engineering and construction, the public observation seminar for intelligent construction projects in the pharmaceutical industry, which was held on April 26th, 2025, was co-hosted by Asia-Pacific HVAC Magazine, China Electronic Systems Engineering Third Construction Co., Ltd, and China Veterinary Pharmaceutical Association Biosafety Branch co-sponsored the public welfare observation seminar of the pharmaceutical industry's clean plant and laboratory intelligent construction projects, which was held in Lanzhou, which enjoys the title of “the Yellow River Capital and the Summer Palace in the West”. The seminar was held in Lanzhou, which is known as the “Yellow River Capital and Western Summer Palace”. The observation seminar gathered top experts, enterprise representatives and technical elites to discuss the development path of technological innovation and intelligent construction of clean plants and laboratories in the pharmaceutical industry. Li Yi, assistant general manager and general manager of Southwest Region of CLP Power Hong Kong Limited, Xie Jingxin, researcher of pharmaceutical industry experts, Li Xiaobin, teacher of China Veterinary Pharmaceutical Association Bio-safety Branch, Hu Zhuping, deputy editor-in-chief of Asia-Pacific Construction Science and Technology Information Research Institute Limited “Heating, Ventilation and Air Conditioning” Magazine, Huo Jinpeng, deputy chief engineer and general manager of Technology Management Center of CLP Power Hong Kong Limited with the company's team of technical engineers and project management team, Liang Lei, deputy director of Construction Science and Technology Purification Center, Zhejiang Meiyi Energy Liang Lei, Deputy Director of the Center, Xiao Peng, Deputy General Manager of Zhejiang Meiyang Design Institute, and 40 experts and representatives from Sinonwit Bio-technology Company Limited, Lanzhou Bio-pharmaceutical Factory of China Maket Industry Company Limited, Lanzhou Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Jiangsu Yiming Bio-technology Company Limited, Toshiba Air Conditioning Equipment (Suzhou) Company Limited, York (China) Trading Company Limited, and Spessartic Engineering (China) Co. Ltd., York (China Trade) Co., Ltd. and Spessac Engineering (China) Co.
On behalf of the organizer, Li Yi, assistant general manager and general manager of Southwest Region of CLP3, delivered a speech for this meeting. Mr. Li firstly expressed his warm welcome and heartfelt thanks to all the experts and friends for their presence. He said that at present China's pharmaceutical industry is in the key stage of innovation and upgrading, the national innovative drug catalog, PIC/S international standard benchmarking, the EU sterile production of new regulations and other policies, the industry has put forward higher requirements. As the main force in the field of pharmaceutical clean engineering construction, CLP3 will give full play to its advantages in technological innovation and management innovation, promote the development of the industry's intelligent, low-carbon and green development, and contribute to the high-quality development of the pharmaceutical industry. Researcher Xie Jingxin emphasized in his speech that cleanroom technological innovation and digital management play a central role in improving drug quality and guaranteeing production safety, and that it is important to coordinate and improve the development of digital intelligence and intelligent supervision of the pharmaceutical industry, and to promote the development of the pharmaceutical industry in a scenario-based and mapping way to promote the high-end, intelligent, green and integrated development of the pharmaceutical industry. Project Observation Seminar is the magazine's form of innovation in the field of pharmaceutical industry, using the project as a carrier, through in-depth analysis and exchange, applying advanced engineering experience to more projects, and applying high-quality equipment (equipment) to more projects. Mr. Xie emphasized that the Good Equipment System is a public welfare activity for the benefit of owners, general contractors and suppliers, and it is an extension of the work of the Laboratory's Good Equipment System, calling for more suppliers to actively participate in it. Mr. Li Xiaobin delivered a speech on behalf of the association, welcoming everyone to the beautiful Lanzhou and visiting and exchanging ideas in high-grade laboratories. The Biosafety Branch of the China Veterinary Pharmaceutical Association, jointly initiated by the College of Animal Medicine and Biosafety of Lanzhou University, Lanzhou Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, and Tianjin Chant Purification Science and Technology Co. Ltd. and other organizations, was approved in December 2023, and looks forward to everyone's attention and active participation. Mr. Li highly appreciated the innovation of this activity form, he pointed out that digital intelligence is the development trend of project construction and management, and proposed that inviting users, builders and excellent suppliers to conduct seminars and exchanges in conjunction with project construction as an important work to promote the development of the industry. HVAC magazine Hu Zhuping introduced in his speech, in order to help China's scientific and technological innovation and the development of new quality of productivity, in recent years, the magazine to industry research, special reports, standards / monographs, featured columns, technical exchanges in the form of General Assembly, the project observation seminars and other forms of scientific laboratories, advanced industries and other areas of work in the series of work, with outstanding results, and I hope that you pay great attention to and actively participate in the event.
The report and exchange session was hosted by Zhang Shisong, Chief Engineer of CLP3's Southern Implementation Center. Huo Jinpeng, Deputy Chief Engineer and General Manager of Technology Management Center of CLP3, took the topic of “Industrial Clean Plant Technology Innovation and Intelligent Construction” and systematically explained the concepts of digital survey, digital design, intelligent production, intelligent construction, intelligent operation and maintenance, as well as the application cases of technological innovation, and analyzed in depth CLP3's Design Collaboration Platform, Visualization Design Technology ( CFD airflow simulation, illumination simulation) BIM technology, BIM4D technology, factory digital simulation technology, digital assembly integration rapid construction technology, lightweight digital technology, construction animation installation handover technology, cloud metering system platform, etc., to enhance the intelligent and green level of project construction. Zhao Weichen, General Manager of Marketing of Digitalization Business Unit, took the topic of “Biomedical Digital Factory Solution Based on Production Command Platform”, focusing on the integration of the whole chain of production data, and demonstrating the implementation path of the equipment health management system and intelligent decision-making system based on digital twins in the GMP workshop. Yanwei Quan, Chief Engineer of Western Implementation Center, took the topic of “Experience and Technology Sharing in Pharmaceutical Project Construction” to introduce the construction technology management process and the standardized management system of pharmaceutical clean plant technology through the example of technology management and technology innovation. Tang Guanhua, Project Manager of Western Implementation Center, took the topic of “Pharmaceutical Project Site Implementation and Difficulties”, focusing on the difficulties and solutions for the site implementation of pharmaceutical clean plants, and analyzing the mature experience of project organization and structure management, progress management, quality management, safety management, and GMP validation.
Back
On behalf of the organizer, Li Yi, assistant general manager and general manager of Southwest Region of CLP3, delivered a speech for this meeting. Mr. Li firstly expressed his warm welcome and heartfelt thanks to all the experts and friends for their presence. He said that at present China's pharmaceutical industry is in the key stage of innovation and upgrading, the national innovative drug catalog, PIC/S international standard benchmarking, the EU sterile production of new regulations and other policies, the industry has put forward higher requirements. As the main force in the field of pharmaceutical clean engineering construction, CLP3 will give full play to its advantages in technological innovation and management innovation, promote the development of the industry's intelligent, low-carbon and green development, and contribute to the high-quality development of the pharmaceutical industry. Researcher Xie Jingxin emphasized in his speech that cleanroom technological innovation and digital management play a central role in improving drug quality and guaranteeing production safety, and that it is important to coordinate and improve the development of digital intelligence and intelligent supervision of the pharmaceutical industry, and to promote the development of the pharmaceutical industry in a scenario-based and mapping way to promote the high-end, intelligent, green and integrated development of the pharmaceutical industry. Project Observation Seminar is the magazine's form of innovation in the field of pharmaceutical industry, using the project as a carrier, through in-depth analysis and exchange, applying advanced engineering experience to more projects, and applying high-quality equipment (equipment) to more projects. Mr. Xie emphasized that the Good Equipment System is a public welfare activity for the benefit of owners, general contractors and suppliers, and it is an extension of the work of the Laboratory's Good Equipment System, calling for more suppliers to actively participate in it. Mr. Li Xiaobin delivered a speech on behalf of the association, welcoming everyone to the beautiful Lanzhou and visiting and exchanging ideas in high-grade laboratories. The Biosafety Branch of the China Veterinary Pharmaceutical Association, jointly initiated by the College of Animal Medicine and Biosafety of Lanzhou University, Lanzhou Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, and Tianjin Chant Purification Science and Technology Co. Ltd. and other organizations, was approved in December 2023, and looks forward to everyone's attention and active participation. Mr. Li highly appreciated the innovation of this activity form, he pointed out that digital intelligence is the development trend of project construction and management, and proposed that inviting users, builders and excellent suppliers to conduct seminars and exchanges in conjunction with project construction as an important work to promote the development of the industry. HVAC magazine Hu Zhuping introduced in his speech, in order to help China's scientific and technological innovation and the development of new quality of productivity, in recent years, the magazine to industry research, special reports, standards / monographs, featured columns, technical exchanges in the form of General Assembly, the project observation seminars and other forms of scientific laboratories, advanced industries and other areas of work in the series of work, with outstanding results, and I hope that you pay great attention to and actively participate in the event.
The report and exchange session was hosted by Zhang Shisong, Chief Engineer of CLP3's Southern Implementation Center. Huo Jinpeng, Deputy Chief Engineer and General Manager of Technology Management Center of CLP3, took the topic of “Industrial Clean Plant Technology Innovation and Intelligent Construction” and systematically explained the concepts of digital survey, digital design, intelligent production, intelligent construction, intelligent operation and maintenance, as well as the application cases of technological innovation, and analyzed in depth CLP3's Design Collaboration Platform, Visualization Design Technology ( CFD airflow simulation, illumination simulation) BIM technology, BIM4D technology, factory digital simulation technology, digital assembly integration rapid construction technology, lightweight digital technology, construction animation installation handover technology, cloud metering system platform, etc., to enhance the intelligent and green level of project construction. Zhao Weichen, General Manager of Marketing of Digitalization Business Unit, took the topic of “Biomedical Digital Factory Solution Based on Production Command Platform”, focusing on the integration of the whole chain of production data, and demonstrating the implementation path of the equipment health management system and intelligent decision-making system based on digital twins in the GMP workshop. Yanwei Quan, Chief Engineer of Western Implementation Center, took the topic of “Experience and Technology Sharing in Pharmaceutical Project Construction” to introduce the construction technology management process and the standardized management system of pharmaceutical clean plant technology through the example of technology management and technology innovation. Tang Guanhua, Project Manager of Western Implementation Center, took the topic of “Pharmaceutical Project Site Implementation and Difficulties”, focusing on the difficulties and solutions for the site implementation of pharmaceutical clean plants, and analyzing the mature experience of project organization and structure management, progress management, quality management, safety management, and GMP validation.